2120 W. Greenview Drive
Lucigen was founded in 1998 to develop novel, useful products and technologies
for advancing life science research. Our unique kits and methods are used by
researchers worldwide to achieve dramatic advances in gene cloning,
genomics, and protein expression. These products allow successful cloning of
genes and genomes that have been impossible to obtain with standard methods.
Lucigen’s exclusive DNA library construction services are used worldwide to
streamline genomic research projects, both large and small, saving time,
effort, and research dollars.
Lucigen’s products are used in-house as well to meet the challenges of our
enzyme discovery program. We have isolated novel molecules from organisms
that inhabit -extreme environments, which have remarkable nucleic acid
amplification properties and have proven useful in genomic research,
diagnostics, and drug discovery. In addition, thermostable enzymes that
degrade carbohydrates may increase the efficiency of ethanol biofuel
production. Our discovery of several such enzymes led to the spinoff from
Lucigen of C5•6 Technologies, Inc., in 2006.
Nucleic-acid technologies: PCR